Simeone Joins ViroMissile, Inc. as Clinical Advisor for Cancer Immunotherapy
1 report, 1 independent
Updated Oct 8
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Diane Simeone was appointed as a clinical and strategic advisor to ViroMissile, Inc. on October 8, 2026. Simeone is also the Director of Moores Cancer Center at UC San Diego and holds a professorship at UC San Diego School of Medicine.
From manilatimes.net
Why it matters
The appointments provide scientific, clinical, and business expertise as ViroMissile advances three Phase 1 clinical programs. These programs evaluate intravenously delivered oncolytic virus therapies designed to treat tumors.
From manilatimes.net
Who's involved
- SimeoneAppointed clinical and strategic advisor to ViroMissile, Inc.
- UC San Diego School of MedicineHolds a formal academic position as Professor of Surgery and Pharmacology
Keep exploring
The entities involved
-
Simeone
British musician
Nothing else this week.
-
UC San Diego School of Medicine
medical school
Nothing else this week.